Inventor · disambiguated record
Lingyun Wu
Also filed as: WU LINGYUN
24 granted patents·13 pending applications·13 citations·filing 2009–2023
91Inventor score
Files withMEDSHINE DISCOVERY INC13HELIOEAST PHARMACEUTICAL CO LTD4CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD3GUANGDONG RAYNOVENT BIOTECH CO LTD3CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD2
Top patents by PatentIndex Score
37 records- 0184US11433053B2LSD1 inhibitor and preparation method and application thereofCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2018·Granted Sep 6, 2022·3 cites·30 claims
- 0279US11345678B2Benzopyrazole compound used as RHO kinase inhibitorMEDSHINE DISCOVERY INC·Filed 2019·Granted May 31, 2022·2 cites·19 claims
- 0379US10278973B2Hydroxyl purine compounds and use thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted May 7, 2019·2 cites·10 claims
- 0477US11760751B2Benzo 2-azaspiro[4.4]nonane compound and use thereofHELIOEAST PHARMACEUTICAL CO LTD·Filed 2021·Granted Sep 19, 2023·1 cites·16 claims
- 0577US9856264B2Isoquinolinesulfonyl derivative as RHO kinase inhibitorMEDSHINE DISCOVERY INC·Filed 2015·Granted Jan 2, 2018·3 cites·19 claims
- 0675US10981900B2Spiro compound and use thereofMEDSHINE DISCOVERY INC·Filed 2018·Granted Apr 20, 2021·1 cites·22 claims
- 0771US10399981B2Crystal form A of 7-(cyclopropylmethyl)-1-(((cis )-4-hydroxy-4-methylcyclohexyl)methyl)-3-methyl-1H-purine-2,6-(3H,7H)-dione for treating liver diseasesGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted Sep 3, 2019·1 cites·17 claims
- 0858US12024494B2Salt of LSD1 inhibitor and a polymorph thereofCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2019·Granted Jul 2, 2024·0 cites·7 claims
- 0957US11702400B2Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kinase inhibitorsMEDSHINE DISCOVERY INC·Filed 2020·Granted Jul 18, 2023·0 cites·13 claims
- 1057US2023331696A1Salt form of isoquinolinone type compound as rock inhibitor and preparation method thereforGUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 1157US2024383906A15-substituted pyridine-2(1h)-ketone compound and use thereofJIANGSU KANION PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1256US2024208945A16-carbamate substituted heteroaryl ring derivativesMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 1356US2025034099A1Benzoxazinone derivativesCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 1455US12492215B2Pyrrolotriazine compounds acting as MNK inhibitorJUMBO DRUG BANK CO LTD·Filed 2022·Granted Dec 9, 2025·0 cites·20 claims
- 1555USRE49128EHydroxyl purine compounds and applications thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2015·Granted Jul 12, 2022·0 cites·22 claims
- 1655US2024150335A1Fused ring derivatives containing 1,4-oxazepaneMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 1754US2024166610A1Substituted pyridazine phenol derivativesMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 1853US11465995B2Crystal and salt forms of tricyclic compound and preparation process thereofSHIJIAZHUANG SAGACITY NEW DRUG DEV COMPANY LTD·Filed 2019·Granted Oct 11, 2022·0 cites·19 claims
- 1953US2024254144A1Salt form of pyrrolotriazine compound, crystal form thereof, and preparation method thereforJUMBO DRUG BANK CO LTD·Filed 2022·Application pending·0 cites
- 2052US2024199571A1Thiophene compound and application thereofMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 2152US2011230497A1Biologically active amidesLUNDBECK & CO AS H·Filed 2009·Application pending·0 cites
- 2250US11524941B2Pyrazole compounds as LSD1 inhibitors and applications thereofMEDSHINE DISCOVERY INC·Filed 2021·Granted Dec 13, 2022·0 cites·18 claims
- 2350US2024182457A1Oxadiazole-substituted spirocyclic compound and application thereofHELIOEAST PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2449US12479794B2Acetophenone oxime compound and application thereofMEDSHINE DISCOVERY INC·Filed 2021·Granted Nov 25, 2025·0 cites·15 claims
- 2548US2023124301A1Tricyclic compounds and use thereofHELIOEAST PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2647US2022402917A1Compound as small molecule inhibitor pd-1/pd-l1 and application thereofMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 2747US2022119431A1Salt of egfr inhibitor, crystal form, and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 2846US12365686B2Compound as porcupine inhibitor and use thereofJIANGSU KANION PHARMACEUTICAL CO LTD·Filed 2020·Granted Jul 22, 2025·0 cites·16 claims
- 2945US12459918B2Isoquinolinone derivatives serving as rock protein kinase inhibitors and use thereofGUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO LTD·Filed 2020·Granted Nov 4, 2025·0 cites·25 claims
- 3045US11192886B2S1P1 agonist and application thereofMEDSHINE DISCOVERY INC·Filed 2017·Granted Dec 7, 2021·0 cites·45 claims
- 3145US11155559B2Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activityCHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD·Filed 2018·Granted Oct 26, 2021·0 cites·11 claims
- 3244US10098885B2Hydroxyl purine compounds and applications thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 16, 2018·0 cites·19 claims
- 3343US11390625B2Aryl-phosphorus-oxygen compound as EGFR kinase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jul 19, 2022·0 cites·16 claims
- 3443US11040984B2Quinazoline compound for EGFR inhibitionMEDSHINE DISCOVERY INC·Filed 2017·Granted Jun 22, 2021·0 cites·24 claims
- 3542US11649245B2Cyclopropylamine compound as LSD1 inhibitor and use thereofHELIOEAST PHARMACEUTICAL CO LTD·Filed 2019·Granted May 16, 2023·0 cites·15 claims
- 3638US9586931B2Triazolyl derivatives as Syk inhibitorsMACHACEK MICHELLE R·Filed 2013·Granted Mar 7, 2017·0 cites·15 claims
- 3736US11046720B2Dimethylphosphine oxide compoundGUIZHOU INOCHINI TECH CO LTD·Filed 2019·Granted Jun 29, 2021·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Lingyun Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →